Accenture: The Dividend Compounder Trading at a Value Price
ACN trades at 14.4x forward earnings with a 100th-percentile EPS predictability score and 40x interest coverage. The market is pricing it like a utility. The business is still growing bookings at double digits. The Chowder Rule on ACN is 16.2%, clearing the 15% quality compounder threshold. Forward…
Published: 2026-03-10 by GNG Research
Tickers: ACN, IBM, INFY, CTSH
By GNG Research | March 2026 There is a particular kind of frustration that only value investors understand. You watch a great business get repriced violently lower, your screen lights up green across every fundamental metric, and yet the stock keeps falling. The tape is relentless. The narrative is brutal. Every instinct trained by years of momentum-chasing whispers to wait, to let it bottom, to find something cleaner. That frustration is exactly where Accenture ( ACN ) sits right now, and I think it is wrong to wait.
This is a members-only GNG Research article. Read the full analysis with a GNG Research plan.